Legal Representation
Attorney
Jong H Park
USPTO Deadlines 2 active 2 overdue
| Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
|---|---|---|---|---|---|
|
OPPOSITION
Notice of Publication |
NPUB | Aug 06, 2020 | 1796 days overdue | Medium | Until Sep 06, 2020 |
|
ITU SOU
Notice of Allowance Mailed - SOU Required |
NOAM | Mar 01, 2021 | 1589 days overdue | High | Until Sep 01, 2021 |
Application History
35 events| Date | Code | Type | Description |
|---|---|---|---|
| Sep 28, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Aug 26, 2021 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Aug 25, 2021 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Aug 19, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Aug 19, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Aug 19, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Aug 5, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Aug 2, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Jul 21, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Jul 21, 2021 | IUAF | S | USE AMENDMENT FILED |
| Mar 3, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Mar 1, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Mar 1, 2021 | EXT1 | S | SOU EXTENSION 1 FILED |
| Mar 1, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Sep 1, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jul 7, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jul 7, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jun 17, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jun 4, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Jun 4, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jun 4, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jun 4, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jun 3, 2020 | ALIE | A | ASSIGNED TO LIE |
| May 26, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| May 21, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| May 21, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| May 21, 2020 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| May 21, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Dec 4, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Dec 4, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Dec 4, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Nov 25, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
| Sep 10, 2019 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Sep 9, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Aug 29, 2019 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
product development, namely, development of cell therapy products; research services in the field of cell separation; biomedical research services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; genetic testing, namely, biological information check, for medical research use; product development, namely, biologics development; research in the field of biologics; biological analysis; consultancy in the field of analysis of biology sequence processing for medical research purposes; multiple nucleotide sequence analysis for scientific research purposes; DNA sequence analysis for scientific research purposes
First Use Anywhere:
Sep 17, 2019
First Use in Commerce:
Mar 17, 2020
Class 044
immunotherapy services related to the treatment of cancers; medical services relating to the removal, treatment and processing of human cells for the purpose of stem cell therapy; analysis of human tissues for medical treatment purposes; providing a database featuring information regarding immune cells for medical purposes; medical services relating to the removal, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bone marrow for medical treatment purposes; medical and health services relating to DNA screening for medical purposes; genetic testing for medical purposes; provision of gene therapy for medical purposes; medical analysis services for the diagnosis and prognosis of cancer; medical analysis services for the diagnosis and prognosis of cancer, namely, RNA or DNA analysis for cancer diagnosis and prognosis; providing information in the field of cancer prevention, screening, diagnosis and treatment; medical analysis services for diagnostic and treatment purposes provided by medical laboratories
First Use Anywhere:
Sep 17, 2019
First Use in Commerce:
Mar 17, 2020
Additional Information
Design Mark
The mark consists of the word "TAST" surrounded by an oblong, with a four point star in the center of the letter "A".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
042
044